The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms
Citri, A., & Malenka, R. C. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301559 · Cited by 2,323 · cited 1×
“Ser845 phosphorylation is well known to increase GluR1 trafficking to the plasma membrane and is critical for multiple forms of synaptic plasticity including long-term potentiation and long-term depression (Shepherd and Huganir, 2007; Citri and Malenka, 2008).”
BackgroundNeurotransmitters and neuromodulators in the basal ganglia
Graybiel, A. M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90104-i · Cited by 1,576
Moy, S. S., Nadler, J. J., Perez, A., Barbaro, R. P., Johns, J. M., Magnuson, T. R., Piven, J., & Crawley, J. N. (2004) · Genes, Brain and Behavior · doi:10.1111/j.1601-1848.2004.00076.x · Cited by 1,522
The primate basal ganglia: Parallel and integrative networks
Haber, S. N. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.10.003 · Cited by 1,479 · cited 1×
“It is clear that the striatum and prefrontal cortex (PFC) are highly interconnected through neuronal circuitry (Haber, 2003).”
BackgroundLongitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS
Green, M. F., Kern, R. S., & Heaton, R. K. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.009 · Cited by 1,422
Graybiel, A. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00593-5 · Cited by 1,051
The cell biology of synaptic plasticity: AMPA receptor trafficking
Shepherd, J. D., & Huganir, R. L. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123516 · Cited by 978
Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit
Roche, K. W., O'Brien, R. J., Mammen, A. L., Bernhardt, J., & Huganir, R. L. (1996) · Neuron · doi:10.1016/s0896-6273(00)80144-0 · Cited by 812
Greengard, P., Allen, P. B., & Nairn, A. C. (1999) · Neuron · doi:10.1016/s0896-6273(00)80798-9 · Cited by 746
Harrison, P. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1761-y · Cited by 693
Institute of Laboratory Animal Resources.
Wolfle, T. L. (1995) · Cited by 620
Swerdlow, N. R., & Geyer, M. A. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033326 · Cited by 617
Molecular determinants of NMDA receptor internalization
Roche, K. W., Standley, S., McCallum, J., Dune Ly, C., Ehlers, M. D., & Wenthold, R. J. (2001) · Nature Neuroscience · doi:10.1038/90498 · Cited by 550
Kellendonk, C., Simpson, E. H., Polan, H. J., Malleret, G., Vronskaya, S., Winiger, V., Moore, H., & Kandel, E. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.023 · Cited by 520
Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial
Keefe, R. S. E., Bilder, R. M., Harvey, P. D., Davis, S. M., Palmer, B. W., Gold, J. M., Meltzer, H. Y., Green, M. F., Miller, D. D., Canive, J. M., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301072 · Cited by 472 · cited 1×
“Schizophrenia has additional symptom domains, the socalled “negative symptoms” as exemplified by anhedonia, asociality, and blunted affect and cognitive deficits (Harvey et al., 2004; Keefe et al., 2006; Makinen et al., 2008).”
BackgroundNegative Symptoms and Cognitive Deficits: What Is the Nature of Their Relationship?
Harvey, P. D., Koren, D., Reichenberg, A., & Bowie, C. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj011 · Cited by 462
Phosphodiesterases in the CNS: targets for drug development
Menniti, F. S., Faraci, W. S., & Schmidt, C. J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2058 · Cited by 391
Immunohistochemical localization of PDE10A in the rat brain
Seeger, T. F., Bartlett, B., Coskran, T. M., Culp, J. S., James, L. C., Krull, D. L., Lanfear, J., Ryan, A. M., Schmidt, C. J., Strick, C. A., et al. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02754-9 · Cited by 334
Young, J. W., Powell, S. B., Risbrough, V., Marston, H. M., & Geyer, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.004 · Cited by 298
Immunohistochemical Localization of Phosphodiesterase 2A in Multiple Mammalian Species
Stephenson, D. T., Coskran, T. M., Wilhelms, M. B., Adamowicz, W. O., O'Donnell, M. M., Muravnick, K. B., Menniti, F. S., Kleiman, R. J., & Morton, D. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.953471 · Cited by 289
Distinct Roles of PDE4 and PDE10A in the Regulation of cAMP/PKA Signaling in the Striatum
Nishi, A., Kuroiwa, M., Miller, D. B., O'Callaghan, J. P., Bateup, H. S., Shuto, T., Sotogaku, N., Fukuda, T., Heintz, N., Greengard, P., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2518-08.2008 · Cited by 286
Schmidt, C. J., Chapin, D. S., Cianfrogna, J., Corman, M. L., Hajos, M., Harms, J. F., Hoffman, W. E., Lebel, L. A., McCarthy, S. A., Nelson, F. R., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132910 · Cited by 284
Drug-induced stimulation and suppression of action monitoring in healthy volunteers
de Bruijn, E. R. A., Hulstijn, W., Verkes, R. J., Ruigt, G. S. F., & Sabbe, B. G. C. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1915-6 · Cited by 282
Siuciak, J. A., Chapin, D. S., Harms, J. F., Lebel, L. A., McCarthy, S. A., Chambers, L., Shrikhande, A., Wong, S., Menniti, F. S., & Schmidt, C. J. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.013 · Cited by 278
Neuropsychological evidence for frontostriatal dysfunction in schizophrenia
Elliott, R., McKenna, P. J., Robbins, T. W., & Sahakian, B. J. (1995) · Psychological Medicine · doi:10.1017/s0033291700033523 · Cited by 267
Tan, H.-Y., Callicott, J. H., & Weinberger, D. R. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm069 · Cited by 266
Immunohistochemical Localization of Phosphodiesterase 10A in Multiple Mammalian Species
Coskran, T. M., Morton, D., Menniti, F. S., Adamowicz, W. O., Kleiman, R. J., Ryan, A. M., Strick, C. A., Schmidt, C. J., & Stephenson, D. T. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6a6930.2006 · Cited by 251
Crawley, J. N., Chen, T., Puri, A., Washburn, R., Sullivan, T. L., Hill, J. M., Young, N. B., Nadler, J. J., Moy, S. S., Young, L. J., et al. (2007) · Neuropeptides · doi:10.1016/j.npep.2007.02.002 · Cited by 232 · cited 1×
“Time spent in the social and empty chambers were expressed as a percentage of the total test period, and because the time spent in each chamber is not an independent measure planned, comparisons between social and empty chambers were made using the Least Squared Means test (Crawley et al., 2007).”
MethodSankoorikal, G. M. V., Kaercher, K. A., Boon, C. J., Lee, J. K., & Brodkin, E. S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.026 · Cited by 231
Siuciak, J. A., McCarthy, S. A., Chapin, D. S., Fujiwara, R. A., James, L. C., Williams, R. D., Stock, J. L., McNeish, J. D., Strick, C. A., Menniti, F. S., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.01.012 · Cited by 231
Hoffman, D. C., & Donovan, H. (1995) · Psychopharmacology · doi:10.1007/bf02246184 · Cited by 223
Harvey, P. D., Green, M. F., Keefe, R. S. E., & Velligan, D. I. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0312 · Cited by 215
PDE10A inhibition reverses subchronic PCP‐induced deficits in attentional set‐shifting in rats
Rodefer, J. S., Murphy, E. R., & Baxter, M. G. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03937.x · Cited by 199
Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase
Xie, Z., Adamowicz, W. O., Eldred, W. D., Jakowski, A. B., Kleiman, R. J., Morton, D. G., Stephenson, D. T., Strick, C. A., Williams, R. D., & Menniti, F. S. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.042 · Cited by 198
Wadenberg, M.-L. G., & Hicks, P. B. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00037-8 · Cited by 188
A GluR1-cGKII Interaction Regulates AMPA Receptor Trafficking
Serulle, Y., Zhang, S., Ninan, I., Puzzo, D., McCarthy, M., Khatri, L., Arancio, O., & Ziff, E. B. (2007) · Neuron · doi:10.1016/j.neuron.2007.09.016 · Cited by 174
Negative symptoms in schizophrenia—A review
Mäkinen, J., Miettunen, J., Isohanni, M., & Koponen, H. (2008) · Nordic Journal of Psychiatry · doi:10.1080/08039480801959307 · Cited by 171
Wadenberg, M.-L. G., Kapur, S., Soliman, A., Jones, C., & Vaccarino, F. (2000) · Psychopharmacology · doi:10.1007/s002130000466 · Cited by 158
Rolipram: A specific phosphodiesterase 4 inhibitor with potential antipsychotic activity
Kanes, S. J., Tokarczyk, J., Siegel, S. J., Bilker, W., Abel, T., & Kelly, M. P. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.026 · Cited by 158
Self-citationMarquis, K. L., Sabb, A. L., Logue, S. F., Brennan, J. A., Piesla, M. J., Comery, T. A., Grauer, S. M., Ashby, C. R., Nguyen, H. Q., Dawson, L. A., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106989 · Cited by 146
Self-citationRutten, K., Prickaerts, J., & Blokland, A. (2005) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2005.09.002 · Cited by 132
Threlfell, S., Sammut, S., Menniti, F. S., Schmidt, C. J., & West, A. R. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146332 · Cited by 131
Menniti, F. S., Chappie, T. A., Humphrey, J. M., & Schmidt, C. J. (2007) · PubMed · Cited by 114
The Role of Phosphodiesterases in Schizophrenia: Therapeutic Implications
Siuciak, J. A. (2008) · CNS Drugs · doi:10.2165/0023210-200822120-00002 · Cited by 100
Alcohol-induced retrograde memory impairment in rats: prevention by caffeine
Spinetta, M. J., Woodlee, M. T., Feinberg, L. M., Stroud, C., Schallert, K., Cormack, L. K., & Schallert, T. J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1294-5 · Cited by 98
Sano, H., Nagai, Y., Miyakawa, T., Shigemoto, R., & Yokoi, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05152.x · Cited by 95
Kelly, M. P., Isiegas, C., Cheung, Y.-F., Tokarczyk, J., Yang, X., Esposito, M. F., Rapoport, D. A., Fabian, S., Siegel, S. J., Wand, G. S., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301099 · Cited by 73
Self-citationOn the nature of Wisconsin Card Sorting Test performance in schizophrenia
Haut, M. W., Cahill, J., Cutlip, W. D., Stevenson, J. M., Makela, E. H., & Bloomfield, S. M. (1996) · Psychiatry Research · doi:10.1016/0165-1781(96)02940-x · Cited by 71
Kelly, M. P., Stein, J. M., Vecsey, C. G., Favilla, C. G., Yang, X., Bizily, S. P., Esposito, M., Wand, G. S., Kanes, S., & Abel, T. G. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.124 · Cited by 69
Self-citationBrooks, J. M., Sarter, M. F., & Bruno, J. P. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.006 · Cited by 45
Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine
Weber, M., Breier, M. R., Ko, D., Thangaraj, N., Marzan, D., & Swerdlow, N. R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1419-x · Cited by 37
Paglia, M. J., Mou, H., & Cote, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106328200 · Cited by 27
Cited by
Advances in targeting cyclic nucleotide phosphodiesterases
Maurice, D. H., Ke, H., Ahmad, F., Wang, Y., Chung, J., & Manganiello, V. C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4228 · Cited by 776
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Francis, S. H., Blount, M. A., & Corbin, J. D. (2011) · Physiological Reviews · doi:10.1152/physrev.00030.2010 · Cited by 639
Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 573
A Possible Role for the Striatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia
Simpson, E. H., Kellendonk, C., & Kandel, E. (2010) · Neuron · doi:10.1016/j.neuron.2010.02.014 · Cited by 478
Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.025 · Cited by 385
Metadata
- Authors
- Grauer, S. M., Pulito, V. L., Navarra, R. L., Kelly, M. P., Kelley, C., Graf, R., Langen, B., Logue, S., Brennan, J., Jiang, L., Charych, E., Egerland, U., Liu, F., Marquis, K. L., Malamas, M., Hage, T., Comery, T. A., & Brandon, N. J.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 331
- Issue
- 2
- Pages
- 574-590
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2130392097
- Cited by
- 269
- References
- 53
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.